Traws Pharma, Inc. (NASDAQ: TRAW, the Company), a clinical-stage biopharmaceutical company developing novel therapies for critical global viral threats, today announced that ...
Preview this article 1 min The agency said it wants to end what it calls a system of "racial favoritism" with a new role that ...
This How Oregon Works interview highlights what’s possible when workforce development is built into major public investments: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results